Tirzepatide (Mounjaro, Zepbound) targets GLP-1 and GIP, with a metabolic advantage that promotes fat breakdown while helping preserve muscle mass
However, outliers were analyzed for these correlations using the interquartile range (IQR) method
GLP-1 acts on the GLP-1 receptor (GLP-1R) to lower blood glucose through enhanced glucose-dependent secretion of insulin, inhibition of glucagon secretion and slowed gastric emptying
GH release peaks during slow-wave sleep, and sermorelin appears to enhance both sleep quality and GH release during sleep (Van Cauter et al., 2000)
Constructed with NotebookLM using Kaneto H et al (2021) and Wexler (2025) as information resources
For a closer look at common digestive effects, read about common GLP-1 side effects